Showing results (11-20 of 84) with videos related to
Sort By:
Pageof 9
Bulletin Du Cancer|August 8, 2016
[Are cancer outpatients ready for e-medicine?]Emmanuelle Kempf, Audrey Prévost, Benoit Rousseau, et al.Journal for Immunotherapy of Cancer|December 1, 2019
Angiogenesis and immune checkpoint inhibitors as therapies for hepatocellular carcinoma: current knowledge and future research directionsMarc Hilmi, Cindy Neuzillet, Julien Calderaro, et al.Applied Optics|June 21, 2007
Prediction of the thermal radiative properties of an x-ray mu-tomographied porous silica glassBenoit Rousseau, Domingos de Sousa Meneses, Patrick Echegut, et al.Plos Neglected Tropical Diseases|January 7, 2016
Trypanosoma brucei gambiense Infections in Mice Lead to Tropism to the Reproductive Organs, and Horizontal and Vertical TransmissionNicolas Biteau, Corinne Asencio, Julien Izotte, et al.Clinical Neurology and Neurosurgery|April 3, 2012
Impact of the per-operatory application of GLIADEL wafers (BCNU, carmustine) in combination with temozolomide and radiotherapy in patients with glioblastoma multiforme: efficacy and toxicityPetra Miglierini, Mohamed Bouchekoua, Benoit Rousseau, et al.Biofabrication|January 21, 2025
In vivo vessel connection of pre-vascularised 3D-bioprinted gingival connective tissue substitutesRawen Smirani, Chantal Medina, Julie Becker, et al.Breast Cancer Research : BCR|December 21, 2014
Humanization of the mouse mammary gland by replacement of the luminal layer with genetically engineered preneoplastic human cellsStephanie Verbeke, Elodie Richard, Elodie Monceau, et al.Cardiovascular and Interventional Radiology|October 15, 2024
Systemic Immunological Changes After Yttrium-90 Radioembolization: A Pilot Prospective Observational Study-Clinical InsightsYuliya Kitsel, Elena N Petre, Phillip Wong, et al.Breast Cancer Research : BCR|September 18, 2015
Erratum to: Humanization of the mouse mammary gland by replacement of the luminal layer with genetically engineered preneoplastic human cellsStephanie Verbeke, Elodie Richard, Elodie Monceau, et al.Investigational New Drugs|November 1, 2011
Sorafenib exposure decreases over time in patients with hepatocellular carcinomaJennifer Arrondeau, Olivier Mir, Pascaline Boudou-Rouquette, et al.Pageof 9